Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / No-core / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man

Composition

• Hex:3 HexNAc:2 NeuAc:2 (avg mass : 1493.3483 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 2 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)[Gal(b1-3)]GalNAc

Composition

• Hex:2 HexNAc:2 dHex:1 (avg mass : 894.8331 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• N-Linked / Complex / Gal(?1-4)GlcNAc(?1-2)Man(a1-3)[Gal(?1-4)GlcNAc(?1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc

Composition

• Hex:5 HexNAc:4 (avg mass : 1641.5073 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 5 / GalNAc(a1-3)GalNAc

Composition

• HexNAc:2 (avg mass : 424.4053 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)GalNAc

Composition

• Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 8 / Gal(a1-3)GalNAc

Composition

• Hex:1 HexNAc:1 (avg mass : 383.3527 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / No-core / Gal(b1-4)GlcNAc(b1-2)Man

Composition

• Hex:2 HexNAc:1 (avg mass : 545.4951 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / No-core / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man

Composition

• Hex:3 HexNAc:2 NeuAc:1 (avg mass : 1202.0904 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 1 / Gal(b1-3)GalNAc

Composition

• Hex:1 HexNAc:1 (avg mass : 383.3527 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 0 / GalNAc

Composition

• HexNAc:1 (avg mass : 221.2103 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]GalNAc

Composition

• Hex:2 HexNAc:2 NeuAc:1 (avg mass : 1039.948 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 2 / Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc

Composition

• Hex:2 HexNAc:2 NeuAc:1 (avg mass : 1039.948 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GalNAc

Composition

• Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / No-core / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man

Composition

• Hex:3 HexNAc:2 NeuAc:1 (avg mass : 1202.0904 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 2 / Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]GalNAc

Composition

• Hex:2 HexNAc:2 (avg mass : 748.6901 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / No-core / GlcNAc(b1-2)Man

Composition

• Hex:1 HexNAc:1 (avg mass : 383.3527 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc

Composition

• Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / Core 1 / Gal(b1-3)[NeuAc(a2-6)]GalNAc

Composition

• Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / No-core / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man

Composition

• Hex:2 HexNAc:1 NeuAc:1 (avg mass : 836.753 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide

Taxonomy

• Oryctolagus cuniculus (Rabbit)

Protein

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    

Source

• Brain (UBERON_0000955)  

Reported structure

• O-Linked / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man

Composition

• Hex:2 HexNAc:1 dHex:1 (avg mass : 691.6381 )

Disease

Reference

• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed

Reported glycosite

• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site

Mass spectrometry observed peptide